Trials in Anaheim, California
Here are the top 10 medical studies for prostate cancer in Anaheim, California
Popular Filters
Phase 3 Trials
Taxane
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Cerritos, California
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Radiation
Shorter vs Usual Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is comparing two different types of radiation therapy for high-risk prostate cancer. One type, called stereotactic body radiation therapy (SBRT), involves giving higher doses of radiation over a shorter period
Hormone Therapy
AZD5305 for Prostate Cancer
Recruiting1 awardPhase 3
Montebello, California
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Trials With No Placebo
Antibody-Drug Conjugate
Dato-DXd Combination Therapy for Advanced Cancers
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing Dato-DXd, a targeted cancer treatment, in patients with advanced or metastatic solid tumors. The treatment aims to deliver chemotherapy directly to cancer cells, helping to kill them while reducing harm to healthy cells.
Gonadotropin-Releasing Hormone (GnRH) Antagonist
ORGOVYX for Prostate Cancer
Recruiting1 award
Duarte, California
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Radiopharmaceutical
Lu-177 Ludotadipep for Prostate Cancer
Recruiting2 awardsPhase 1 & 2
Los Angeles, California
This trial tests the safety and effectiveness of a radioactive drug called [177Lu]Ludotadipep. The drug works by delivering radiation directly to certain cells to treat the condition. Lutetium-177 (177Lu) has been widely used in targeted therapy, particularly in peptide receptor radionuclide therapy (PRRT) for treating neuroendocrine tumors.
Radiation
177Lu-PSMA with Biopsy for Prostate Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial studies how well a targeted radiation treatment works in patients with advanced prostate cancer that doesn't respond to hormone therapy. The treatment aims to kill cancer cells by delivering radiation directly to them.
Antibody-drug conjugate
MGC018 + MGD019 for Solid Tumors
Recruiting1 awardPhase 1
Los Angeles, California
This trial tests two experimental drugs on patients with advanced cancers that haven't responded to other treatments. One drug aims to kill cancer cells directly, while the other boosts the immune system to fight the cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.